Ethics of JSBCH Publishing
Details of formal ethical approval should be stated in the main body of the article. If authors were not required to obtain ethical approval (as is the case in some countries) or unable to obtain it (as sometimes occurs in resource-poor settings), they should explain the reason. Please anonymize this information in the manuscript, and only if requested give the information during submission. The procedures for securing informed consent should be provided.
Complying with medical ethics, anonymity, and confidentiality are among the points to be considered. In this regard, protecting the human subjects according to Helsinki Declaration should be taken in to consideration and the ethics committee confirmation letter of the university must be attached to the article. Medical research studies involving human subjects must generally be accepted in terms of scientific principles and a letter of consent from parents or legal caretakers is necessary.
According to ICMJE website "A Clinical Trial is any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". Authors who conducted studies in this scope should register their trial in one of the ICMJE-recognized trial registries. Therefore, the number of clinical trial registration should be attached to submitted paper.
Ethics of studies involving humans and animals
The research that involves human beings and animals must adhere to the principles of the Declaration of Helsinki (http://www.wma.net/en/30publications/10policies/b3/index.html).
All research participants should be informed about the aims of the study and any possible side effects of the drugs and intervention. Written informed consent under protocols approved by an institutional or local review board or approved animal protocols are essential if the research involves human or animal subjects, respectively. This information should be stated in the manuscript and the protocol number or exempt status of approved protocols should be stated in the manuscript at the time of submission for review. Ethical considerations must be clearly addressed in the Methods section. Also the name of the appropriate institutional review board that approved the project should be mentioned. The Journal reserves the right to request the related documents.
The privacy rights of human subjects must always be observed and attention should be paid to the principles of participants' anonymity and information confidentiality, and those should be clearly mentioned in the manuscript.
Clinical Trial Registration
In a clinical trial, According to the International Committee of Medical journal Editors (ICMJE), participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or changes to participants' behavior, such as diet. Clinical trials may compare a new medical approach to a standard one that is already available, to a placebo that contains no active ingredients, or to no intervention. Some clinical trials compare interventions that are already available to each other. The investigators try to determine the safety and efficacy of the intervention by measuring certain outcomes in the participants. Authors of clinical trials are required to prospectively register their trial with one of the ICMJE-recognized trial registries. The registration number of the trial and the name of the trial registry must be mentioned at the end of the abstract.
All of Iranian Clinical Trials must be registered in Iranian Registry of Clinical Trials (www.IRCT.ir), in order to be considered for publication. The clinical trials performed abroad, could be considered for publication, if they register in a registration site approved by W.H.O. such as:
Authorship Criteria and contributions
Authors' names should be mentioned according to the defined criteria by the International Committee of Medical Journal Editors (ICMJE). Based on the ICMJE recommendations, authors (or one of them) should have all the following criteria: 1) Have a substantial contribution in at least one of the following activities: a) presenting the research conception or designing the study, b) collecting the data, c) analyzing and interpreting; 2) Have a role in drafting the study or revising it critically for important intellectual scientific content; 3) Study and approve the final version to be published; 4) Agree to be accountable for the correctness and accuracy of all aspects of the study; 5) The journal avoids accepting the articles with moral plagiarism (scientific and literary) and fraud according to the existing standards. The contents of the article should not be a copy of similar studies. If the authors use all or part of the published or unpublished materials or ideas of someone else, they must cite references properly or take permission in necessary cases. Useful guidelines for authors can be found on the ICMJE website. In cases of authorship disputes that can not be resolved between the authors, the editors reserve the right to refer the dispute to the institutes involved for resolution. Useful guidelines for researchers on how to avoid authorship disputes can be found on the COPE website. Enter author's all contributions in the submission system during submission.
Contributions will be published in the final article, and they should accurately reflect contributions in the study. The submitting author is responsible for completing this information at submission, and it is expected that all authors, prior to this time, will have reviewed, discussed, and agreed upon their individual contributions. The contributions of all authors must be described using the CRediT Taxonomy of author's roles.
Role of the Corresponding Author
One author is assigned as Corresponding Author and acts on behalf of all co-authors and ensures that questions related to the accuracy or integrity of any part of the work are appropriately addressed. The ICMJE recommends that authorship be based on the following 4 criteria:
In addition to being accountable for the parts of the work he or she has done, an author should be able to identify which co-authors are responsible for specific other parts of the work. In addition, authors should have confidence in the integrity of the contributions of their co-authors.
Addition, deletion, or rearrange Addition, deletion, or rearrangement of author names in an accepted manuscript’s authorship
Before the accepted manuscript is published in an online issue
Requests to add or remove an author, or to rearrange the author names, must be sent to the Journal Manager from the corresponding author of the accepted manuscript and must include:
a) The reason the name should be added or removed, or the author names rearranged.
b) Written confirmation (email, fax, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed.
Requests that are not sent by the corresponding author will be forwarded on by the Journal Manager to the corresponding author, who must follow the procedure as described above.
Note that:
JSBCH will follow the COPE guidelines to deal with any potential misconduct. Scientific misconduct includes fabrication, falsification, and plagiarism with the intent to deceive by the authors. Honest error or differences in interpretation are not considered misconduct. Breaches of publication ethics include but are not limited to: failure to reveal financial conflicts of interest; omitting a deserving author or adding a noncontributing author; misrepresenting publication status in the reference list; self-plagiarism without attribution; duplicate or redundant publication; and inclusion of one or more sentences verbatim from another source without citing the original source and putting the sentence(s) in quotation marks.
JSBCH takes seriously its responsibility to ensure scientific integrity and will pursue any allegations of misconduct. The JSBCH editors adhere to the COPE Code of Conduct, which can be found at http://publicationethics.org/resources/code-conduct. Charges of academic dishonesty, including plagiarism, duplicate, and redundant publication will be managed according to COPE guidelines. JSBCH uses Small SEO Tools plagiarism checker software to verify the originality of written works.
If the Scientific Integrity Panel concludes there is a reasonable possibility of misconduct, they will consider any of the following options, dependent upon the apparent magnitude of the misconduct. Responses may be applied separately or combined, and their implementation will depend on the circumstances of the case as well as the responses of the participating parties and institutions. The following options are ranked in approximate order of severity:
A letter of explanation (and education) sent only to the person(s) against whom the complaint is made, where there appears to be a genuine and innocent misunderstanding of principles or procedure.
A letter of reprimand to the person(s) against whom the complaint is made, warning of the consequences of future such instances, where the misunderstanding appears to be not entirely innocent.
A letter of reprimand to all co-authors on the paper informing them of the findings of the Panel and warning of the consequences of future such instances.
A formal letter as above, including a written request to the supervising institution(s) that an investigation be carried out and the findings of that inquiry be reported in writing to the journal.
Publication of a notice of redundant or duplicate publication or plagiarism, if appropriate and unequivocally documented. Such publication will not require approval of authors, and may also be reported to their institution and, if appropriate, funding agency.
Formal withdrawal or retraction of the paper from the scientific literature, published in the journal.
Note: If the author wants to submit his/her manuscript for publication in another periodical, he/she should first withdraw his/her paper from JSBCH journal. For that, author should mail the Editor-in-chief or the handling editor about the withdrawal decision along-with proper reasons for the same. Once he/she receive the response, he/she is free to communicate it anywhere else.
Duplication
To avoid duplication, consider the points established by COPE website.
a) Author(s) should clarify that they has not been submitted the manuscript in more than one journal.
b) Author(s) should not publish the submitted manuscript in two different languages (one in a Persian medical journal and the other in another language (English, French, German, etc.), simultaneously.
c) Author(s) should not publish the submitted manuscript in JSBCH elsewhere previously as part or full, unless some new results would be considered.
d) Authors should not split up the results of a work to publish them in more than one journal (Salami-Publishing).
Author(s) should enclose a written undertaking along with manuscript, confirming the above mentioned points with signature of the corresponding author(s).
Plagiarism includes:
If plagiarism is detected during the peer review process, the manuscript may be rejected. If plagiarism is detected after publication, JSBCH may perform a correction or retract the paper, as appropriate. JSBCH reserves the right to inform authors' institutions about plagiarism detected either before or after publication. The journal uses plagiarism detection software to evaluate the originality of each manuscript before publication.
JSBCH expects that editors and reviewers will be vigilant in their evaluation of JSBCH submissions and will notify the journal about any plagiarism identified. Authors should avoid self-plagiarism. It means they do not use the previous own published materials without acknowledgment of the source.
ORCID
JSBCH mandates ORCID iDs for the first and corresponding authors since 2018. Therefore, authors and reviewers are strongly recommended to also connect their Scholar One accounts to ORCID.
Conflicts of Interest
According to ICMJE guidelines, a conflict of interest may exist when an author (or the author’s institution), reviewer or editor has personal or financial relationships that influence (bias) inappropriately his/her action (such relationships are also known as dual commitments, competing interests, or competing loyalties). These relationships vary from those with negligible potential to those with great potential to influence judgment, and not all relationships represent true conflict of interest. The potential for conflict of interest can exist whether or not an individual believes that the relationship affects his or her scientific judgment. Financial relationships (such as employment, consultancies, stock ownership, honoraria, paid expert testimony) are the most easily identifiable conflicts of interest and the most likely to undermine the credibility of the journal, the authors, and of science itself. However, conflicts can occur for other reasons, such as personal relationships, academic competition, and intellectual passion.
Authors must make sure that they have declared any actual or potential conflicts of interest in their manuscript when submitting their work. The corresponding author is responsible for confirming with the co-authors whether they have any conflicts to be declared or not.
Copyright Policy
JSBCH is licensed under a Creative Commons Attribution 4.0 International License
:Impoetant Note which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.The license ensures that the article will be available as widely as possible and that the article can be included in any scientific archive. While submitting your manuscript please bear in mind to upload Authorship Statement and Copyright Form as well (this form must be completed and signed by corresponding author).
Complaints Procedure
This procedure is about the complaints about the publishing policies, procedures and actions of publishing and editorial staff and Editors-in-Chief of journals from JSBCH.
JSBCH infers that the complainants can not simply disagreeing with a decision that JSBCH has made or has published unless there has been a failure of process - for example, a long delay or a rude response - or a severe misjudgment.
JSBCH welcomes complaints as they provide an opportunity and a spur for improvement, and JSBCH aims to respond quickly, courteously, and constructively. Please write your complaint with journal title, vol. no., issue no., paper title and page no.
How to Make a Complaint
Advertising Policy
This journal does not carry advertising. All the related costs are supplied by Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Data sharing policy
The data sharing policy in JSBCH is the same as the ones that came in the last updated edition in ICMJE (www.icmje.org/update.html) and we will be committed to implementing them.
Journal of Social Behavior and Community Health encourages data sharing as this is a crucial issue asked by most funding sources. Sharing data help reproducibility, lowers duplication, and allows re-use and purposing. JSBCH supports Data DOIs as persistent.
Archiving Policy
The articles published by JSBCH are archived on our website and also in multiple international databases around the world including increasing visibility and long-term digital preservation.
These archives include:
Google Scholar
DOAJ (Directory of Open Access Journals)
Index Copernicus
ISC (Islamic World Science Citation Center)
SID (Scientific Information Database)
MAGIRAN
All journal issues are archived in the library of School of Public Health in Shahid Sadoughi University of Medical Sciences.
Open Access Policy